These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 32850417)

  • 1. Tumor Testing for Somatic and Germline
    Peixoto A; Pinto P; Guerra J; Pinheiro M; Santos C; Pinto C; Santos R; Escudeiro C; Bartosch C; Canário R; Barbosa A; Gouveia A; Petiz A; Abreu MH; Sousa S; Pereira D; Silva J; Teixeira MR
    Front Oncol; 2020; 10():1318. PubMed ID: 32850417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The detection of germline and somatic BRCA1/2 genetic variants through parallel testing of patients with high-grade serous ovarian cancer: a national retrospective audit.
    Frugtniet B; Morgan S; Murray A; Palmer-Smith S; White R; Jones R; Hanna L; Fuller C; Hudson E; Mullard A; Quinton AE
    BJOG; 2022 Feb; 129(3):433-442. PubMed ID: 34657373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Sensitivity of Germline and Somatic
    Vendrell JA; Ban IO; Solassol I; Audran P; Cabello-Aguilar S; Topart D; Lindet-Bourgeois C; Colombo PE; Legouffe E; D'Hondt V; Fabbro M; Solassol J
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline and somatic variants in ovarian carcinoma: A next-generation sequencing (NGS) analysis.
    Andrikopoulou A; Zografos E; Apostolidou K; Kyriazoglou A; Papatheodoridi AM; Kaparelou M; Koutsoukos K; Liontos M; Dimopoulos MA; Zagouri F
    Front Oncol; 2022; 12():1030786. PubMed ID: 36531003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Untapped Potential of Poly(ADP-Ribose) Polymerase Inhibitors: Lessons Learned From the Real-World Clinical Homologous Recombination Repair Mutation Testing.
    Lebedeva A; Veselovsky E; Kavun A; Belova E; Grigoreva T; Orlov P; Subbotovskaya A; Shipunov M; Mashkov O; Bilalov F; Shatalov P; Kaprin A; Shegai P; Diuzhev Z; Migiaev O; Vytnova N; Mileyko V; Ivanov M
    World J Oncol; 2024 Aug; 15(4):562-578. PubMed ID: 38993246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation Patterns in Portuguese Families with Hereditary Breast and Ovarian Cancer Syndrome.
    Vicente R; Alpuim Costa D; Vitorino M; Mendes AD; Santos C; Fontes-Sousa M
    Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Globally Rare
    Oosthuizen J; Kotze MJ; Van Der Merwe N; Myburgh EJ; Bester P; van der Merwe NC
    Front Oncol; 2020; 10():619469. PubMed ID: 33643918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine Plasma-Based Genotyping to Comprehensively Detect Germline, Somatic, and Reversion
    Vidula N; Rich TA; Sartor O; Yen J; Hardin A; Nance T; Lilly MB; Nezami MA; Patel SP; Carneiro BA; Fan AC; Brufsky AM; Parker BA; Bridges BB; Agarwal N; Maughan BL; Raymond VM; Fairclough SR; Lanman RB; Bardia A; Cristofanilli M
    Clin Cancer Res; 2020 Jun; 26(11):2546-2555. PubMed ID: 32034076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene Panel Tumor Testing in Ovarian Cancer Patients Significantly Increases the Yield of Clinically Actionable Germline Variants beyond
    Barbosa A; Pinto P; Peixoto A; Guerra J; Pinto C; Santos C; Pinheiro M; Escudeiro C; Bartosch C; Silva J; Teixeira MR
    Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 33008098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity.
    Pinto P; Paulo P; Santos C; Rocha P; Pinto C; Veiga I; Pinheiro M; Peixoto A; Teixeira MR
    Breast Cancer Res Treat; 2016 Sep; 159(2):245-56. PubMed ID: 27553368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining the Diagnostic Yield of Tumour Testing and Qualifying Germline Concordance for Hereditary Cancer Variants in Patients with High-Grade Serous Carcinoma.
    Goebel EA; Kerkhof J; Dzyubak O; McLachlin CM; McGee J; Sadikovic B
    Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deleterious somatic variants in 473 consecutive individuals with ovarian cancer: results of the observational AGO-TR1 study (NCT02222883).
    Hauke J; Hahnen E; Schneider S; Reuss A; Richters L; Kommoss S; Heimbach A; Marmé F; Schmidt S; Prieske K; Gevensleben H; Burges A; Borde J; De Gregorio N; Nürnberg P; El-Balat A; Thiele H; Hilpert F; Altmüller J; Meier W; Dietrich D; Kimmig R; Schoemig-Markiefka B; Kast K; Braicu E; Baumann K; Jackisch C; Park-Simon TW; Ernst C; Hanker L; Pfisterer J; Schnelzer A; du Bois A; Schmutzler RK; Harter P
    J Med Genet; 2019 Sep; 56(9):574-580. PubMed ID: 30979843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing.
    Mafficini A; Simbolo M; Parisi A; Rusev B; Luchini C; Cataldo I; Piazzola E; Sperandio N; Turri G; Franchi M; Tortora G; Bovo C; Lawlor RT; Scarpa A
    Oncotarget; 2016 Jan; 7(2):1076-83. PubMed ID: 26745875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1/2 NGS Somatic Testing in Clinical Practice: A Short Report.
    Pepe F; Pisapia P; Russo G; Nacchio M; Pallante P; Vigliar E; De Angelis C; Insabato L; Bellevicine C; De Placido S; Troncone G; Malapelle U
    Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of BRCA1 and BRCA2 germline mutations in Japanese population using next-generation sequencing.
    Hirotsu Y; Nakagomi H; Sakamoto I; Amemiya K; Mochizuki H; Omata M
    Mol Genet Genomic Med; 2015 Mar; 3(2):121-9. PubMed ID: 25802882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition.
    Vos JR; Fakkert IE; de Hullu JA; van Altena AM; Sie AS; Ouchene H; Willems RW; Nagtegaal ID; Jongmans MCJ; Mensenkamp AR; Woldringh GH; Bulten J; Leter EM; Kets CM; Simons M; Ligtenberg MJL; Hoogerbrugge N;
    J Natl Cancer Inst; 2020 Feb; 112(2):161-169. PubMed ID: 31076742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas.
    Weren RD; Mensenkamp AR; Simons M; Eijkelenboom A; Sie AS; Ouchene H; van Asseldonk M; Gomez-Garcia EB; Blok MJ; de Hullu JA; Nelen MR; Hoischen A; Bulten J; Tops BB; Hoogerbrugge N; Ligtenberg MJ
    Hum Mutat; 2017 Feb; 38(2):226-235. PubMed ID: 27767231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next-generation sequencing based detection of
    Hua D; Tian Q; Wang X; Bei T; Cui L; Zhang B; Bao C; Bai Y; Zhao X; Yuan P
    Front Oncol; 2022; 12():898916. PubMed ID: 36147908
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of Homologous Recombination Deficiency in Ovarian Cancer.
    Ratnaparkhi R; Javellana M; Jewell A; Spoozak L
    Curr Treat Options Oncol; 2024 Feb; 25(2):237-260. PubMed ID: 38300479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Impact of Somatic Variants in Homologous Recombination Repair-Related Genes in Ovarian High-Grade Serous Carcinoma.
    Choi MC; Hwang S; Kim S; Jung SG; Park H; Joo WD; Song SH; Lee C; Kim TH; Kang H; An HJ
    Cancer Res Treat; 2020 Apr; 52(2):634-644. PubMed ID: 32019284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.